LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents.
第一作者:
Kelly S,Chien
第一单位:
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
作者:
医学主题词
人类(Humans);免疫疗法(Immunotherapy);白血病, 粒-单核细胞, 慢性(Leukemia, Myelomonocytic, Chronic);白血病, 粒-单核细胞, 幼年型(Leukemia, Myelomonocytic, Juvenile);膜糖蛋白类(Membrane Glycoproteins);骨髓增生异常综合征(Myelodysplastic Syndromes);受体, 免疫(Receptors, Immunologic);增量调节(Up-Regulation)
DOI
10.1080/10428194.2020.1723014
PMID
32036728
发布时间
2022-05-31
- 浏览7
Leukemia & lymphoma
1493-1499页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



